RepHQ runs live today on the UK's National Joint Registry — the largest arthroplasty registry in the world. RepHQ Global is the same platform pointed at every country with a comparable registry: the same twelve segments, the same onboarding, the same honesty about what the data shows. One country is live; ten more are mapped and pending.
The RepHQ model needs one thing from a country: a national arthroplasty registry publishing surgeon-level or hospital-level volume. These are the countries that have one. The UK is live; the rest are labelled pending, plainly, until they are not.
The proving ground. RepHQ runs live on NJR data today — every other country on this page follows the same blueprint.
Europe’s biggest joint replacement market, with a registry built around an implant product database — a natural fit for the RepHQ model.
The country that invented the arthroplasty registry. Coverage is near-total and the data culture is decades deep.
One register, every joint — the closest structural match to the NJR outside the UK.
Three registers rather than one, but the same surgeon-and-site volume picture underneath.
Four decades of mandatory national reporting across every joint RepHQ segments.
The most complete registry in continental Europe, covering more joints than the NJR itself.
A compact, high-value market where registry documentation is mandatory — capture is close to total.
The southern-hemisphere benchmark. Near-total capture and an annual report the whole industry reads.
A five-joint registry that mirrors the NJR’s scope — the cleanest like-for-like expansion on the list.
The biggest orthopaedic market on earth, with a registry that is already the world’s largest by procedure count.
This is the part that does not vary by company — or by country. It is loaded, maintained and quality-checked by RepHQ, and it is what makes every segment above it worth switching on. Pricing for the core is agreed per contract and is not published.
Surgeon-level and hospital-level procedure volumes, per joint, per year, from the country's national arthroplasty registry — the base every market-share figure is projected from.
Ratings held against the specific rated construct — not the brand family — using the benchmark the market actually quotes, with lapsed and withdrawn entries tracked rather than hidden.
Published patient-reported outcome and revision data, matched to the hospitals on the patch where the country publishes it.
Curated public and private site list from national provider registers, with licence-verified surgeons and their sites — including private practice.
Every relationship, preference, volume and action is recorded against the territory, not the individual. A leaver hands over a running patch.
One-tap visit capture with a sync queue, camera and clipboard capture, and offline PDF caching for theatre corridors with no signal.
A global orthopaedic company and a single-territory distributor buy the same platform. What differs is which country, how many segments are switched on, and how much of it is shaped to their own portfolio.
Registry data, hospitals, surgeons, visit logging, territory continuity, admin hierarchy, sync and support — per country.
Hip Primary, Knee Primary, Shoulder, and nine more. Each one is a discrete billable unit: onboarding, your catalogue, segment-filtered navigation and segment-level reporting. Onboard three, pay for three.
Market share per segment, your device library and techniques, custom fields, CRM sync and branding, and tender and framework watch — each scoped to the segments you have onboarded.
Segment keys, labels and behaviour are identical in every country — a global company sees one model everywhere. What changes per country is which segments the national registry backs with volume; the rest run on recorded activity and say so.
Demand sets the rollout order. Name the country and the segments, and we will show you what the registry there already makes possible.
Talk to us